The first all-oral regimen for treating the hepatitis C virus has been approved by the US FDA. Gilead Science's sofosbuvir was given unanimous backing by the 15 members of the panel.
Read our coverage of this treatment development here:
FDA gives its seal of approval to new he... - Hepatitis C Trust
FDA gives its seal of approval to new hep C drug
Written by
Hep_C_News_team
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
Moderation team
sam_hepctrustPartner